Developing story — details emerging. Check the source link for the latest updates.
Source: [Yahoo Finance](https://finance.yahoo.com/technology/ai/articles/australia-nab-test-ai-agent-114723259.html)
Developing story — details emerging. Check the source link for the latest updates.
Lilly’s sales were driven by higher-than-expected demand for Mounjaro and Zepbound, its GLP-1 drugs for Type 2 diabetes and weight loss.
Developing story — details emerging. Check the source link for the latest updates.
Developing story — details emerging. Check the source link for the latest updates.
Developing story — details emerging. Check the source link for the latest updates.
Developing story — details emerging. Check the source link for the latest updates.